Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer

Figure 6

Bar graph of concentrations of discrepant biomarkers among early-stage NSCLC, lung benign disease (LBD), and healthy controls (HC) groups. The black horizontal lines are median values. P values are determined by Fisher’s least significant test.